vs

Side-by-side financial comparison of Henry Schein (HSIC) and QVC INC (QVCD). Click either name above to swap in a different company.

Henry Schein is the larger business by last-quarter revenue ($3.4B vs $2.4B, roughly 1.4× QVC INC). Henry Schein runs the higher net margin — 2.9% vs 1.5%, a 1.4% gap on every dollar of revenue. On growth, Henry Schein posted the faster year-over-year revenue change (7.7% vs -8.9%). Over the past eight quarters, QVC INC's revenue compounded faster (7.1% CAGR vs 4.1%).

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners. For 14 consecutive years, the company has been named as one of the World's Most Ethical Companies by Ethisphere, most recently in 2025.

QVC Group, is an American media conglomerate controlled by company chairman John C. Malone, who owns a majority of the voting shares.

HSIC vs QVCD — Head-to-Head

Bigger by revenue
HSIC
HSIC
1.4× larger
HSIC
$3.4B
$2.4B
QVCD
Growing faster (revenue YoY)
HSIC
HSIC
+16.7% gap
HSIC
7.7%
-8.9%
QVCD
Higher net margin
HSIC
HSIC
1.4% more per $
HSIC
2.9%
1.5%
QVCD
Faster 2-yr revenue CAGR
QVCD
QVCD
Annualised
QVCD
7.1%
4.1%
HSIC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HSIC
HSIC
QVCD
QVCD
Revenue
$3.4B
$2.4B
Net Profit
$101.0M
$37.0M
Gross Margin
30.9%
32.5%
Operating Margin
4.7%
5.6%
Net Margin
2.9%
1.5%
Revenue YoY
7.7%
-8.9%
Net Profit YoY
7.4%
103.0%
EPS (diluted)
$0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HSIC
HSIC
QVCD
QVCD
Q4 25
$3.4B
$2.4B
Q3 25
$3.3B
$2.0B
Q2 25
$3.2B
$2.0B
Q1 25
$3.2B
$1.9B
Q4 24
$3.2B
$2.7B
Q3 24
$3.2B
$2.1B
Q2 24
$3.1B
$2.1B
Q1 24
$3.2B
$2.1B
Net Profit
HSIC
HSIC
QVCD
QVCD
Q4 25
$101.0M
$37.0M
Q3 25
$101.0M
$2.0M
Q2 25
$86.0M
$-2.2B
Q1 25
$110.0M
$-42.0M
Q4 24
$94.0M
$-1.2B
Q3 24
$99.0M
$51.0M
Q2 24
$104.0M
$53.0M
Q1 24
$93.0M
$51.0M
Gross Margin
HSIC
HSIC
QVCD
QVCD
Q4 25
30.9%
32.5%
Q3 25
30.7%
33.6%
Q2 25
31.4%
35.4%
Q1 25
31.6%
33.3%
Q4 24
31.1%
32.6%
Q3 24
31.3%
34.7%
Q2 24
32.5%
35.6%
Q1 24
31.9%
35.0%
Operating Margin
HSIC
HSIC
QVCD
QVCD
Q4 25
4.7%
5.6%
Q3 25
4.9%
4.6%
Q2 25
4.7%
-114.5%
Q1 25
5.5%
1.5%
Q4 24
4.9%
-47.1%
Q3 24
4.9%
7.8%
Q2 24
5.1%
7.6%
Q1 24
4.7%
7.4%
Net Margin
HSIC
HSIC
QVCD
QVCD
Q4 25
2.9%
1.5%
Q3 25
3.0%
0.1%
Q2 25
2.7%
-109.1%
Q1 25
3.5%
-2.2%
Q4 24
2.9%
-46.0%
Q3 24
3.1%
2.4%
Q2 24
3.3%
2.5%
Q1 24
2.9%
2.4%
EPS (diluted)
HSIC
HSIC
QVCD
QVCD
Q4 25
$0.85
Q3 25
$0.84
Q2 25
$0.70
Q1 25
$0.88
Q4 24
$0.75
Q3 24
$0.78
Q2 24
$0.80
Q1 24
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HSIC
HSIC
QVCD
QVCD
Cash + ST InvestmentsLiquidity on hand
$156.0M
$1.5B
Total DebtLower is stronger
$2.3B
$1.0M
Stockholders' EquityBook value
$3.2B
$1.2B
Total Assets
$11.2B
$8.5B
Debt / EquityLower = less leverage
0.71×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HSIC
HSIC
QVCD
QVCD
Q4 25
$156.0M
$1.5B
Q3 25
$136.0M
Q2 25
$145.0M
Q1 25
$127.0M
Q4 24
$122.0M
$297.0M
Q3 24
$126.0M
$297.0M
Q2 24
$138.0M
$315.0M
Q1 24
$159.0M
$311.0M
Total Debt
HSIC
HSIC
QVCD
QVCD
Q4 25
$2.3B
$1.0M
Q3 25
$2.2B
$5.0B
Q2 25
$2.1B
$4.0B
Q1 25
$2.0B
$4.0B
Q4 24
$1.8B
$3.3B
Q3 24
$1.9B
$3.4B
Q2 24
$1.9B
$3.7B
Q1 24
$2.0B
$3.8B
Stockholders' Equity
HSIC
HSIC
QVCD
QVCD
Q4 25
$3.2B
$1.2B
Q3 25
$3.4B
$1.2B
Q2 25
$3.4B
$1.2B
Q1 25
$3.3B
$3.3B
Q4 24
$3.4B
$3.3B
Q3 24
$3.5B
$4.6B
Q2 24
$3.5B
$4.3B
Q1 24
$3.6B
$4.2B
Total Assets
HSIC
HSIC
QVCD
QVCD
Q4 25
$11.2B
$8.5B
Q3 25
$11.1B
$8.3B
Q2 25
$10.9B
$7.4B
Q1 25
$10.5B
$9.7B
Q4 24
$10.2B
$9.9B
Q3 24
$10.6B
$9.9B
Q2 24
$10.3B
$11.2B
Q1 24
$10.1B
$11.4B
Debt / Equity
HSIC
HSIC
QVCD
QVCD
Q4 25
0.71×
0.00×
Q3 25
0.64×
4.30×
Q2 25
0.61×
3.42×
Q1 25
0.59×
1.22×
Q4 24
0.54×
1.01×
Q3 24
0.54×
0.73×
Q2 24
0.54×
0.87×
Q1 24
0.56×
0.89×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HSIC
HSIC
QVCD
QVCD
Operating Cash FlowLast quarter
$381.0M
$245.0M
Free Cash FlowOCF − Capex
$338.0M
FCF MarginFCF / Revenue
9.8%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
3.77×
6.62×
TTM Free Cash FlowTrailing 4 quarters
$573.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HSIC
HSIC
QVCD
QVCD
Q4 25
$381.0M
$245.0M
Q3 25
$174.0M
$76.0M
Q2 25
$120.0M
$52.0M
Q1 25
$37.0M
$46.0M
Q4 24
$204.0M
$189.0M
Q3 24
$151.0M
$98.0M
Q2 24
$296.0M
$164.0M
Q1 24
$197.0M
$84.0M
Free Cash Flow
HSIC
HSIC
QVCD
QVCD
Q4 25
$338.0M
Q3 25
$141.0M
Q2 25
$88.0M
Q1 25
$6.0M
Q4 24
$168.0M
Q3 24
$117.0M
Q2 24
$259.0M
Q1 24
$156.0M
FCF Margin
HSIC
HSIC
QVCD
QVCD
Q4 25
9.8%
Q3 25
4.2%
Q2 25
2.7%
Q1 25
0.2%
Q4 24
5.3%
Q3 24
3.7%
Q2 24
8.3%
Q1 24
4.9%
Capex Intensity
HSIC
HSIC
QVCD
QVCD
Q4 25
1.3%
Q3 25
1.0%
Q2 25
1.0%
Q1 25
1.0%
Q4 24
1.1%
Q3 24
1.1%
Q2 24
1.2%
Q1 24
1.3%
Cash Conversion
HSIC
HSIC
QVCD
QVCD
Q4 25
3.77×
6.62×
Q3 25
1.72×
38.00×
Q2 25
1.40×
Q1 25
0.34×
Q4 24
2.17×
Q3 24
1.53×
1.92×
Q2 24
2.85×
3.09×
Q1 24
2.12×
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HSIC
HSIC

Global Dental Merchandise$1.2B35%
Global Medical$1.1B31%
Global Dental Equipment$536.0M16%
Global Specialty Products$422.0M12%
Global Technology$173.0M5%
Global Value Added Services$64.0M2%
Equity Method Investee$14.0M0%

QVCD
QVCD

Home$754.0M31%
QVC International$661.0M27%
Beauty$260.0M11%
Apparel$254.0M10%
Electronics$187.0M8%
Accessories$181.0M7%
Jewelry$87.0M4%
Otherrevenue$38.0M2%

Related Comparisons